Pfizer Inc. said on Tuesday U.S. regulators have approved its blockbuster cholesterol drug Lipitor to reduce the risk of Stroke and Heart Attack in diabetic patients.

Pfizer said the approval is for patients with type 2, or adult onset, diabetes who have no signs of Heart disease but have multiple risk factors for the condition.

Common risk factors include High cholesterol, High Blood Pressure, a family history of Heart disease, Smoking and Obesity.